X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NIH Guide: BREAST CANCER EDUCATION MINI-SUMMITS

Full Text CA-93-18

BREAST CANCER EDUCATION MINI-SUMMITS

NIH GUIDE, Volume 22, Number 3, January 22, 1993

RFA:  CA-93-18

P.T. 34

Keywords: 


Application Receipt Date:  May 7, 1993

PURPOSE

The purpose of this Request for Applications (RFA) is to provide
support for the planning, implementation, and evaluation of Breast
Cancer Education Mini-Summits.  These mini-summits are intended as
follow-up to other breast cancer education programs designed to
educate and encourage leaders of community organizations, businesses,
and/or health organizations to establish breast cancer education and
screening programs, such as the Breast Cancer Educations Summits
funded under RFA CA-91-27.  The present RFA provides applicant
institutions opportunities to develop and conduct focused programs
that are tailored to the needs of more defined target audiences, as
opposed to the large-scale summits that will be funded under a
different RFA and will provide a comprehensive introduction to
screening and education programs aimed at a broad audience.

The overall intent of the mini-summits and large-scale summits is the
same:  to educate and motivate community organizations, business, and
health organizations to establish breast cancer education and
screening programs in the community.  The ultimate aim of all summits
is to reach all women, placing special emphasis on women at high risk
of breast cancer and populations that are medically underserved
and/or hard-to-reach, with information about risks for breast cancer,
the potentially life-saving methods that may detect the cancer in its
most treatable, early stages, and information about how to seek
state-of-the-art treatment.

This RFA is limited to:  (1) NCI-Designated Cancer Centers with P30
grants, (2) institutions with NCI P20 planning grants for prospective
cancer centers, and (3) other institutions with a broad base of
grant-supported research in basic, clinical and prevention and
control science, and that have demonstrated prior experience in
conducting intensive and detailed breast cancer education programs
for one or a few of the target audiences of this RFA.  The target
audiences are community organizations, businesses, government and
other health organizations, and intermediaries that reach medically
underserved and hard-to-reach women.  Relevant medical and scientific
expertise, and the information and education resources, in place and
operational, will best qualify the applicant institutions to (1) plan
and conduct mini-summits with a content that is of greatest practical
and educational benefit and to (2) identify and reach target
audiences of this RFA.  The applicant institutions should have strong
ties within the community with voluntary community organizations,
corporate leaders, state and local health departments, and other
intermediaries with access to medically underserved and hard-to-reach
populations.  This access ensures dissemination of highly relevant
information to the target audiences and the greatest possibility for
achieving an impact on establishment of new breast cancer education
and screening programs.

Qualified institutions are invited to submit applications for hosting
Breast Cancer Education Mini-Summits with NCI and other national and
regional sponsors of the initiative.  Applicants should also include,
when possible, the local Cancer Information Service (CIS) in the
plans for the mini-summit; the CIS can be used as an information
resource for questions concerning early detection and treatment.  The
local and/or divisional chapter of the American Cancer Society should
be included in the mini-summit plans.  Also, the planning committee
for the mini-summit should include minority representatives, as well
as representatives from community organizations with access to the
medically underserved.

NCI will provide for the attendees at each mini-summit written
educational materials to assist organizations in promoting early
detection, to guide businesses in developing worksite programs, to
encourage women to follow NCI recommended breast cancer screening
guidelines and, if needed, to aid in seeking state-of-the art
treatment.  To assist in developing a mini-summit proposal, NCI has
available a "how to host a summit" guide, which was developed for the
large-scale summits but provides information useful in developing any
type of breast cancer education program.  The guide is available from
the NCI Program Directors. In addition, individuals from institutions
eligible to apply for this RFA may attend a workshop about conducting
breast cancer summits, that will be held in Washington, DC on
February 23, 1993.

Pre-registration is required through the contact named in INQUIRIES
below.

HEALTHY PEOPLE 2000

The Public Health Service (PHS) is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2000,"
a PHS-led national activity for setting priority areas.  This RFA,
Breast Cancer Education Mini-Summits, is related to the priority area
of cancer.  Potential applicants may may obtain a copy of "Healthy
People 2000" (Full Report:  Stock No. 017-001-00474-0) or "Healthy
People 2000"  (Summary Report:  Stock No. 017-001-00473-1) thorough
the Superintendent of Documents, Government Printing Office,
Washington, DC 20402-9325 (202-783-3238).

ELIGIBILITY

Eligible institutions may apply for a grant under both this RFA and
RFA CA-93-17 to host a large-scale summit.  However, the geographic
location of cancer centers will be considered to allow broad coverage
of the U.S. population through both the large-scale and mini-summits.
In addition, for this RFA, consideration will be given to the
intended target audiences to ensure that model, or prototype,
mini-summits are developed and conducted that reach all the audiences
of this RFA:  businesses, community organizations, government and
other health organizations, and intermediaries who have access to
medically underserved and hard-to-reach populations.

MECHANISM OF SUPPORT

The administrative and funding mechanism to be used to support these
summits will be the Conference Grant Award (R13).  Responsibility for
the planning, direction, and execution of the proposed project will
be solely that of the applicant.  The total project period for
applications submitted in response to the present RFA may not exceed
one year.  No more than $7,500 will be awarded to a single
institution.  The summits are well-spaced within the time frame of
October 1993 and July 1994.

Applicants are invited to attend a one-day workshop on planning and
conducting a breast cancer summit meeting that will be held in
Washington, DC on February 23, 1993.  Pre-registration is required
through the contact named in INQUIRIES below.

The funds and resources provided by NCI must be used for information
and education purposes only and not for fund-raising activities.

APPLICATION PROCEDURES

The research grant application form PHS-398 (revised 9/91) is to be
used in applying for these grants.  These forms are available at most
institutional offices of sponsored research; from the Office of
Grants Inquiries, Division of Research Grants, National Institutes of
Health, Westwood Building, Room 449, Bethesda, MD 20892, telephone
301-496-7441; and from the NCI Program Director named below.
Applicants may find information on the requirements for conference
grants and supplemental instructions for application form PHS-398 in
the publication on "Support of Scientific Meetings," U.S. Department
of Health and Human Services, August 1988, 8 pp., which can be
obtained from the Office of Grants Inquiries or the Grants Management
contact noted below.

The RFA label must be affixed to the bottom of the face page of the
original copy of the application.  Failure to use this label could
result in delayed processing of the application such that it will not
reach the review committee in time for review.  In addition, the RFA
number and title must be typed on line 2a of the face page of the
application, and the YES box must be marked.

Submit a signed, typewritten original of the application, including
the Checklist, and three signed, photocopies in one package to:

Division of Research Grants
National Institutes of Health
Westwood Building, Room 240
Bethesda, MD  20892**

At time of submission, send two additional copies of the application
to:

Ms. Toby Friedberg, Referral Officer
Division of Extramural Activities
National Cancer Institute
Executive Plaza North, Room 650
6130 Executive Boulevard
Rockville, MD  20892

Applications must be received by May 7, 1993.  If an application is
received after that date, it will be returned to the applicant
without review.  The Division of Research Grants (DRG) will not
accept any application in response to this announcement that is
essentially the same as one currently pending initial review, unless
the applicant withdraws the pending application.  The DRG will not
accept any application that is essentially the same as one already
reviewed.  This does not preclude the submission of substantial
revisions of applications already reviewed, but such applications
must include an introduction addressing the previous critique.

REVIEW CONSIDERATIONS

Upon receipt, applications will be reviewed for completeness by DRG
and responsiveness by the NCI. Incomplete and/or non-responsive
applications will be returned to the applicant without further
consideration.

Those applications judged to be responsive will be further evaluated
according to the review criteria stated below for scientific and
technical merit by an appropriate peer review group convened by the
Division of Extramural Affairs, NCI.  The second level of review will
be conducted by the Executive Committee of the NCI to consider the
special requirements as noted in Section VII and the priorities of
the National Cancer Program.

Proposals responsive to this competitive solicitation will be
reviewed in accordance with the criteria stated below.

1.  The technical merit of the proposed mini-summit, including the
organization and agenda, as well as the proposed evaluation and
follow-up for the program.

2.  The institutional base of grant-supported research in basic,
clinical and prevention and control science.

3.  The institutional expertise available for state-of-the-art cancer
treatment, follow-up, information, and education.

4.  The qualifications and experience of the Principal Investigator
and staff.

5.  The applicant's plans for, and demonstrated access to, minorities
and hard-to-reach medically underserved populations and an
understanding of their needs in order to plan and implement breast
cancer education and/or screening programs.

6.  Demonstration of an understanding of the barriers that may impede
the target audience(s) in developing and implementing breast cancer
education and/or screening programs.

7.  Demonstration of an understanding of the obstacles to access and
utilization of breast cancer education period of support for each
approved application.  No more than $7,500 in total direct costs will
be awarded to a single institution.

AWARD CRITERIA

The anticipated date of award is July 1993.  The primary criteria for
award will be technical merit reflected in the priority score.
However, the geographic location of the cancer centers will be
considered to allow for the broadest coverage of the U.S. population.
In addition, the intended target audience(s) will be considered to
ensure that, taken together, model mini-summits are developed and
conducted that reach all the target audiences of this RFA:  business,
community organizations, government health agencies, and
intermediaries who have access to medically underserved and
hard-to-reach women.

INQUIRIES

Written and telephone inquiries concerning this RFA are encouraged.
The opportunity to clarify any issues or questions from potential
applicants is welcome.

Direct inquiries on programmatic issues to:

Linda M. Muul, Ph.D.
Special Assistant to OCC
Program Director, Cancer Centers Branch
Division of Cancer Biology, Diagnosis and Centers
National Cancer Institute
Executive Plaza North, Room 308
Bethesda, MD  20892
Telephone:  301-496-8531

Direct inquiries regarding fiscal matters to:

Cynthia Mead
Grants Administration Branch
National Cancer Institute
Executive Plaza South, Room 243
Bethesda, MD  20892
Telephone:  (301) 496-7800  Ext. 54

AUTHORITY REGULATIONS

This program is described in the Catalog of Federal Domestic
Assistance No. 93.397.  Cancer Centers Support Awards are under
authorization of the Public Health Service Act, Title IV, Part A
(Public Law 78-410, as amended by Public Law 99-158, 42 USC 241 and
285) and administered under PHS grants policies and Federal
Regulations 42 CFR 52 and 45 CFR Part 74.  This program is not
subject to the intergovernmental review requirements of Executive
Order 12372 or Health Systems Agency Review.

.

Return to RFAs Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.